RE: June 201522 Jun 2020 21:01
Babkfool- agreed!
And yes, this is now a very undervalued pharma and as. Result could offer life changing results for both patient and shareholders!
As I mentioned earlier just in the US 10-20% of child bearing aged woman (regardless of ethnic or social nature) suffer or will suffer from endometriosis.
I made a comment that this could be as big as Viagra, but the thing is if you are in pain or discomfort you have not only a want but a need to get better and aliviate the pain.
So, if this very large Japanese Pharma has studied the found data in detail and have signed an agreement to further study it as a proof of concept, this could be huge.
Now what about 201 to fight certain cancers or even the agreement to study its effects on Covid.
So, if it has anti-viral properties, what else could it be used for in fighting viral infections?
Then you have two dark horses that not much is said about Val101 &401. So, 401 is due some results at any time .
So, all I am saying is dyor but imo there re four possible and likely viable successes here and it wouldn't surprise me one bit if a pharma who is interested (even as a toy thing) started buying shares to take over the conpany.
Just a thought, but if any of these drugs have a viable route to market, we will be snapped up!
This leads me to believe that as the share price rose today it was a product of the placing share being sold off and a lack of liquid shares in the market due to a tiny free float and several sticky hands holding them.
Imo, I see this trading some where between 12p-15p with a 12-13p support and then gradually finding it's way up to the low 20's until news. This could happen sooner, but upon decent news this will fly!